Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping

NCT03548766 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Blood Disease
Blood Transfusion, Autologous
Blood Doping
Blood Transfusion, Homologous

Interventions

BIOLOGICAL: Homologous Blood Transfusion
BIOLOGICAL: Autologous Blood Transfusion

Sponsor

Hamad Medical Corporation

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]